Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to GE Healthcare, Dyax to Develop c-Met Imaging Peptides for Cancer

    • Chromatography Media
    • GE Healthcare Life Sciences
    • HiTrap™ Talon® crude, His SpinTrap™ Talon microspin, His MultiTrap™ Talon, and His GraviTrap™ Talon are prepacked with Talon Superflow™ media for screening, preparative purification, and scale-up of histidine-tagged proteins. Samples derived f
    • Fluorescent Dye
    • Molecular Targeting Technologies
    • CyAL-5 is a monofunctional cyanine dye containing a free carboxylic acid group for conjugation with targeting agents containing a free amine group (e.g., drugs, proteins, peptides, and antibodies) for in vivo and in vitro imaging applications. It i
    • Blue Light Transilluminator
    • Syngene
    • The UltraBright-LED transilluminator is a blue light transilluminator designed for safely imaging fluorescently labelled gels (up to 20 cm x 16 cm) on the bench or inside G:BOX imaging systems. The UltraBright-LED uses two high-intensity LED arrays
    • Fluorescence Dyes
    • PromoCell
    • PromoFluor dyes span the wavelengths spectrum from blue to far red. They show good photostability, strong absorption, high-fluorescence intensity and quantum yields, and good water solubility. They are suited for immunofluorescence microscopy, FACS
    • Sequencing Assays
    • Roche
    • GS GType TET2/CBL/KRAS and the GS GType RUNX1 primer sets are designed for comprehensive genetic variation detection in four key human genes using the 454 GS Junior and GS FLX Systems. The sequence-based assays offer a solution for cancer researche
    • Chromatography Medium
    • GE Healthcare Life Sciences
    • Capto Core 700 is a multimodal chromatography medium (resin) designed for intermediate purification and polishing of viruses and other large biomolecules. Capto Core 700 offers up to 100-fold greater sample loadings and higher flow rates. The mediu
  • Page 3 of 3 (46 items) First 1 2 3 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll